UK markets closed

Aileron Therapeutics, Inc. (ALRN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
5.0000-0.0600 (-1.19%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-15,732
-15,732
-27,329
-26,164
-21,157
Depreciation & amortisation
119
119
169
121
163
Stock-based compensation
1,190
1,190
2,083
2,260
1,893
Change in working capital
-5,381
-5,381
420
242
-1,280
Accounts payable
-4,982
-4,982
510
-386
116
Other working capital
-19,808
-19,808
-24,865
-23,911
-20,481
Net cash provided by operating activities
-19,808
-19,808
-24,865
-23,754
-20,476
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-
-157
-5
Acquisitions, net
-96
-96
0
-
-
Purchases of investments
0
0
-21,850
-73,577
-10,034
Sales/maturities of investments
16,250
16,250
48,309
37,751
16,242
Net cash used for investing activities
16,196
16,196
26,459
-35,917
6,411
Cash flows from financing activities
Common stock issued
-
-
0
55,583
15,413
Other financing activities
15,794
15,794
-
-
-
Net cash used provided by (used for) financing activities
15,794
15,794
0
55,657
15,800
Net change in cash
12,119
12,119
1,594
-4,014
1,735
Cash at beginning of period
5,219
5,219
3,625
7,639
5,904
Cash at end of period
17,338
17,338
5,219
3,625
7,639
Free cash flow
Operating cash flow
-19,808
-19,808
-24,865
-23,754
-20,476
Capital expenditure
-
-
-
-157
-5
Free cash flow
-19,808
-19,808
-24,865
-23,911
-20,481